Navigating legal and ethical pathways for game-based health trials in Ontario

Game-based interventions—serious games, gamified rehabilitation, and therapeutic virtual-reality experiences—are moving from prototypes into clinical research and pilot trials across Ontario. Designing and running an ethically sound, legally compliant trial requires more than good gameplay and experimental rigour. Teams must align study plans with provincial privacy law, federal device regulation, research ethics board requirements, and standards for participant safety and equitable access. That alignment protects participants, preserves data integrity, and strengthens the scientific credibility of trial results.

Ontario and federal regulatory landscape: what trial teams must know

Trials conducted in Ontario operate inside a layered regulatory environment. Provincial rules governing personal health information and healthcare providers interact with federal requirements for medical devices and general privacy protections. Key frameworks to consider include Ontario’s Personal Health Information Protection Act (PHIPA), federal privacy rules where they apply, the Tri-Council Policy Statement on Ethical Conduct for Research Involving Humans (TCPS 2), and Health Canada’s medical device regulations when software or hardware is a device.

Core points for project planning:

• Determine whether your game or software qualifies as a medical device under Health Canada. If it does, device licensing and reporting obligations may apply.
• Identify the role of health information custodians if your trial collects data from or through healthcare institutions—PHIPA governs collection, use, and disclosure of personal health information in Ontario.
• Use the TCPS 2 and local research ethics board (REB) guidance to structure consent processes, risk assessment, and participant protections.

Informed consent, capacity, and meaningful assent

Informed consent for a game-based health trial must be accessible, clear, and tailored to the population. Games can alter engagement, attention, and decision-making states; consent materials must account for those factors. Where participants have fluctuating capacity or cognitive impairment, substitute decision-making rules and ongoing capacity checks are required.

Design consent and assent procedures with these practices:

• Provide layered consent documents: short plain-language summaries up front, with detailed protocols and technical descriptions available for clinicians or curious participants.
• Use multimedia consent aids where appropriate—videos, in-game walkthroughs, or interactive FAQs—to ensure comprehension without coercion.
• Include mechanisms for ongoing consent and easy withdrawal, especially when sessions are remote or data collection continues after interaction ends.
• For minors or adults who lack capacity, follow Ontario law on substitute decision-makers and secure REB approval for consent processes and assent procedures.

Privacy, data management, and cross-jurisdictional concerns

Game-based trials often capture granular behavioural traces, biometric signals, and passive telemetry. That richness increases research value but raises privacy, re-identification, and secondary-use risks. Ontario teams must map data flows carefully and apply technical and administrative safeguards aligned with PHIPA and applicable federal privacy laws.

Practical data controls to include in trial design:

• Data classification and minimization: collect only data necessary to meet study objectives and classify personally identifying health data as high sensitivity.
• De-identification and coding: remove direct identifiers and store keys separately under strict access controls; document re-identification risk and mitigation strategies.
• Storage, transfer and cloud choices: ensure that cloud providers meet Canadian data residency expectations when required, and that contracts include appropriate security and access clauses.
• Clear secondary use and retention policies: state whether data will be reused, for what purposes, and how long it will be retained; obtain specific consent or REB approval for secondary analyses.

Health Canada and device classification for game software

Software that diagnoses, treats, or influences physiological functions can be a medical device. Many game-based therapeutic tools skirt the line between general wellness software and regulated digital therapeutics. Early classification determines whether trial teams need to follow device-specific controls, quality management systems, and reporting obligations under the Medical Devices Regulations.

Steps to manage device-regulation risk:

• Conduct a software-as-a-medical-device (SaMD) assessment: document intended use, claims, and intended user to evaluate whether your game meets Health Canada’s device definition.
• If the product qualifies, adopt quality management practices and maintain technical documentation that supports safety and performance claims.
• Design post-market surveillance plans and adverse event reporting processes compatible with Health Canada expectations—these can overlap with REB safety monitoring.

Research Ethics Boards (REBs) and institutional oversight

All human-participant research at Ontario institutions typically requires REB approval. REBs review risk/benefit balance, consent materials, recruitment, data protection, and plans for vulnerable participants. When a trial involves a regulated device, some institutions require both REB approval and device committee review.

Best practices for REB submissions and engagement:

• Prepare a clear lay summary and specify how gamification elements could affect risks or participant understanding.
• Provide detailed monitoring and escalation plans for adverse effects such as cybersickness, increased anxiety, or physical injury during motion-based tasks.
• Show data management, de-identification, and retention policies, including how data sharing will be governed for collaborators outside Ontario or Canada.
• Engage early with the REB to discuss novel elements like in-game adaptive algorithms or automated interventions that change based on participant behaviour.

Vulnerable participants, equity, and accessibility

Many game-based trials target clinical populations: children, older adults, people with neurological conditions, or populations with limited digital literacy. Ethical design means reducing barriers to participation and preventing exclusion or unintended harm.

Design considerations to improve equity and safety:

• Accessibility by design: ensure visual, auditory, and motor accommodations are present; provide alternative input modes and clear in-game guidance.
• Recruitment equity: use inclusive recruitment strategies to avoid bias toward tech-savvy populations and document inclusion/exclusion rationales for REB review.
• Monitor differential effects: plan subgroup analyses and safety monitoring to detect adverse impacts that may disproportionately affect specific participants.
• Provide appropriate supports: when testing with clinical populations, include clinician oversight, clear withdrawal pathways, and emergency contacts.

Safety monitoring, adverse events, and remote trials

Game-based interventions can produce physical or psychological adverse events—motion sickness, worsening mood, or overexertion. Remote or decentralized trials add complexity for incident detection and participant support.

Safety frameworks to implement:

• Real-time monitoring and reporting: instrument sessions to flag physiological or behavioural markers that suggest distress; establish triage pathways for flagged cases.
• Adverse event definitions and logging: predefine what constitutes an adverse event and ensure staff are trained to record and report events to REBs and, where applicable, Health Canada.
• Remote support infrastructure: provide immediate contact methods and local emergency guidance for remote participants and material for caregivers where relevant.

Intellectual property, commercialization, and conflicts of interest

Trials often sit at the interface of science and product development. Teams must manage intellectual property (IP), disclosure of financial interests, and separation between research aims and commercial promotion.

Recommended governance steps:

• Declare all financial interests to the REB and sponsors; create management plans to reduce bias risk.
• Clarify IP ownership in collaboration agreements and consent forms when data could inform commercial development.
• Separate promotional claims from research communication: avoid therapeutic claims in recruitment or trial materials unless supported by evidence and approved by regulators.

Practical checklist for Ontario game-based health trials

Use this checklist during planning and before recruitment to reduce legal and ethical friction:

• Classify the software: perform Health Canada SaMD assessment and document results.
• Map data flows: identify personal health information, storage location, and cross-border transfer needs; align with PHIPA and federal privacy rules.
• Draft layered consent materials and build multimedia aids to improve comprehension.
• Obtain REB approval and consult device/clinical committees where required.
• Design safety monitoring, adverse event reporting, and withdrawal procedures for both in-person and remote participants.
• Include accessibility features and plan inclusive recruitment to avoid digital divide bias.
• Define data retention, secondary-use consent, and de-identification methods up front.
• Document conflicts of interest and IP arrangements; include them in participant-facing materials if they affect the study.

A pragmatic closing that connects ethics, law, and credible science

Conducting game-based health trials in Ontario requires careful coordination across privacy law, research ethics, medical device regulation, and inclusive design. Teams that plan for these requirements early—by classifying software, clarifying data governance, building accessible consent, and engaging REBs—reduce regulatory risk and produce results that can withstand peer review and regulatory scrutiny. Ethical diligence also protects participants and strengthens public trust in digital health research.

—

How the Association of Registered Web Developers can support Ontario teams

The Association of Registered Web Developers | Canada | Ontario provides regional expertise in technology, VR/AR, health-related development, and clear, practical guidance for teams building trials. We offer technical articles, resources, and community connections that help developers and researchers align game design with legal and ethical expectations in Ontario. Through R.W.D. certification and our knowledge base, trial teams gain credibility and access to best-practice guidance on usability, accessibility, privacy-conscious engineering, and research-ready development. Reach out to the Association of Registered Web Developers to learn how to prepare technical documentation, meet accessibility standards, and present research-ready projects that are positioned for ethical review and successful trial execution in Ontario.